Correlation of CD33 with poorer prognosis in childhood ALL implicates a potential of anti-CD33 frontline therapy

Leukemia. 2005 Jun;19(6):1092-4. doi: 10.1038/sj.leu.2403737.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antigens, CD / immunology*
  • Antigens, CD / metabolism
  • Antigens, Differentiation, Myelomonocytic / immunology*
  • Antigens, Differentiation, Myelomonocytic / metabolism
  • Child
  • Humans
  • Immunophenotyping
  • Incidence
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnosis
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / epidemiology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
  • Prognosis
  • Sialic Acid Binding Ig-like Lectin 3

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • CD33 protein, human
  • Sialic Acid Binding Ig-like Lectin 3